Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.97 USD | +0.17% | +0.06% | +60.45% |
Jun. 05 | Harrow, Inc. Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study | CI |
Jun. 03 | Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.45% | 635M | |
+50.70% | 795B | |
+41.96% | 627B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 294B | |
+18.02% | 245B | |
+1.27% | 222B | |
+11.95% | 215B | |
+3.68% | 160B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Raises Harrow Health's PT to $22 From $17 on Heels of Acquisition of 5 New Ophthalmology Products, Keeps Buy Rating